I was wondering whether anyone could suggest sources of information about amplified genes in cancer, especially if the website tries to combine it with (over)expression information. We wrote a review on amplified and expressed genes recently and are trying to get a sense of what else is out there, so that when we update it we make sure we get different sources of information, not just a search of the literature.
-
-
It would be helpful if you listed the sources that you already have (for the benefit of other users who find this thread and to prevent duplication of resources you are already aware of).
That being said some resources that spring to mind are listed below. Mostly these are initiatives that have created or are in the process of creating data that would provide both amplification and expression data, via next generation whole genome shotgun (WGS) and RNA sequencing (RNA-seq) or copy-number + expression microarrays.
Oncomine [registration required]
The Cancer Genome Anatomy Project (CGAP)
The Cancer Genome Characterization Initiative (CGCI; may soon have relevant data)
The Cancer Genome Atlas (TCGA; relevant data gradually entering the public domain)
The international cancer genome consortium (ICGC)
The database of genomic variants -
Here is a list of the ones we have got already- CONAN (http://www.sanger.ac.uk/cgi-bin/gene...nan/search.cgi)
- Cancer Genome Workbench (https://cgwb.nci.nih.gov/)
- Breast (http://www.itb.cnr.it/breastcancer/)
- Integrative Oncogenomics Cancer Browser - IntOGen (http://www.intogen.org/)
- Oncomine (http://www.oncomine.org/)
Oh, and of course there is our website too: http://amplicon.icr.ac.ukLast edited by danielsbrewer; 09-23-2010, 12:40 AM.Comment
-
We've put together a resource which allows one to query for over-expression and amplification in Cancer genomics samples, particularly those profiled by The Cancer Genome Atlas.
Here are some related threads if you're interested:
Good luck!
------------------------------
GenePool is making genomics data management, analysis, and sharing easier!
Products @ www.stationxinc.comLast edited by GenePool; 11-23-2014, 09:26 PM.Comment
-
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...07-31-2026, 11:01 AM
Comment